Roundtable Discussion; The Future of Mineral Sands. Watch the video here.
Although the CEO stated the company has no control over the share price, it can issue news items which helps sentiment and supports the share price.
Why doesn't the company issue Reach RNS's when positive news is announced by its distributors such as the recent one for Norway......
“The successful launch in Norway of Eroxon® in February was an important and significant event. After only two weeks in the market, this clinically proven local treatment of erectile dysfunction was the bestseller at an online pharmacy. Strong sales in the rest of the first quarter, resulted in Eroxon® ranking third on Navamedic’s most sold products in the Consumer Health segment. Eroxon® will be launched in Sweden in May, and in Finland later this year,” said Kathrine Gamborg, CEO of Navamedic ASA.
https://news.cision.com/navamedic-asa/r/navamedic-q1-2024--successful-product-launch-and-steady-operational-progress,c3970410
Snippets of news like this would go a long way to underpin the share price rather than allow the constant drip, drip downwards. Private investors cannot allow their savings to reduce day after day so consequently have to limit their losses by selling where as Institutional investors hold for the long term. What is the company doing to attract more Institutional investors ?
Hoping you will pass this on to the board, I look forward to hearing their response
Sent to Investor relations today.
In the recent podcast the CEO stated the company has no control of the share price.
I agree they cannot control it but surely they could help it by announcing when distribution begins in new markets such as kdonkey100 reported the Portuguese website is now up and running.
It seems to appear the company want to have a low valuation for some reason or another.
Market report in the Mail this morning puts a negative slant on the results .
"Consumer healthcare firm Futura Medical warned there was some uncertainty over its ability to generate revenue and the timing of key milestone payments.
Last year it made £3.1million following the launch of a gel to treat erectile dysfunction. But it said it was difficult to predict future sales."
It fell 13.6 per cent, or 5.8p, to 37p.
If your shares are held in a nominee acc. at A J Bell, please be aware that there is no corporate action notice logged against RBD. At present you are unable to vote for the motions at the GM. They have assured me it will be available before the deadline of Jan 3rd.
All my share holdings are in nominee accounts. When I want to attend an AGM to vote I ask for a letter of representation from my broker, this then gives me the right to vote.
Can not the takeover shareholders use this option?
David confirmed at the AGM treasury shares would not be used to benefit directors.
Interestingly share buybacks are not being purchased by the nomad but by the company themselves so having complete control over when they purchase and at what price.
As at 1/11/22 Harbour holding was 8.53% .
It was possible to buyback shares during a closed period subject to various conditions in Oct 21, maybe the rules have changed.
https://markets.ft.com/data/announce/detail?dockey=1323-15189142-6OA8RRRDCMKCPUO0VR29S2CIOS
Now have link, https://reabold.com/wp-content/uploads/2023/02/Reabold-Circular-BuybackReductionArticles-09.02.2023-Final.pdf